NBOMes: Difference between revisions
| Line 8: | Line 8: | ||
These chemicals have nearly no history of human use prior to 2010 when they first became available online. | These chemicals have nearly no history of human use prior to 2010 when they first became available online. | ||
The NBOMe family of chemicals is relatively new and very little is known about this group of compounds. These chemicals may only be used with extreme caution. | |||
== 25i-NBOMe Dosage == | == 25i-NBOMe Dosage == | ||
Revision as of 05:23, 14 April 2013
General Information
Classification: Psychedelic (with reported stimulating properties)
History
These chemicals have nearly no history of human use prior to 2010 when they first became available online.
The NBOMe family of chemicals is relatively new and very little is known about this group of compounds. These chemicals may only be used with extreme caution.
25i-NBOMe Dosage
Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).
Oral
Duration: 4-14 hours
Low dose: 200-500 ug (micrograms!)
Medium (typical) dose: 500-1500 ug (micrograms!)
High dose: >1500 ug (micrograms!)
Insufflated
Duration: 3-8 hours
Onset: 0-10 minutes
Low dose: 100 - 400 ug (micrograms!)
Medium (typical) dose: 400 - 700 ug (micrograms!)
High dose: >700 ug (micrograms!)
25c-NBOMe Dosage
Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).
Oral
Duration: 4-11 hours
Low dose: X ug (micrograms!)
Medium (typical) dose: X ug (micrograms!)
High dose: X ug (micrograms!)
Insufflated
Duration: 3-8 hours
Onset: 0-10 minutes
Low dose: 100-300 ug (micrograms!)
Medium (typical) dose: 300-500 ug (micrograms!)
High dose: >500 ug (micrograms!)
Effects
Positive
Neutral
Negative
After effects
- "Hangover"?
- Afterglow
- Long term effects
Harm Reduction
- Avoid driving and operating heavy machinery
- Recommended time (pauses) between using the substance
- Addiction potential?
- Risk of death?
- Mental illness?
- Heart issues?
Chemistry and Pharmacology
Production
Images
-
italic caption
-
-
-
-
Legal
Europe
The -NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011. See http://www.rg.ru/2011/10/19/narko-dok.html
America
The NBOMe series of compounds are unscheduled in the United States. It is possible that some of them would be considered analogs (of scheduled phenethylamines such as 2C-B or mescaline), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. However, Virginia has recently made the 25x-NBOMe series and all its analogues schedule I; expected is that more states are to follow quickly.